| Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications |
44 |
| Molecular characterization of a series of 990 index patients with albinism |
19 |
| Melasma, a photoaging disorder |
16 |
| MITF and UV responses in skin: From pigmentation to addiction |
14 |
| PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival |
13 |
| Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma |
12 |
| Oncogenic signaling in uveal melanoma |
11 |
| NGS-based targeted resequencing identified rare subtypes of albinism: Providing accurate molecular diagnosis for Japanese patients with albinism |
10 |
| Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma |
10 |
| IL-17A is not a treatment target in progressive vitiligo |
9 |
| A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma |
8 |
| Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis |
8 |
| Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome |
8 |
| Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies |
8 |
| Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma |
8 |
| D-tyrosine negatively regulates melanin synthesis by competitively inhibiting tyrosinase activity |
8 |
| Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma |
8 |
| Developmental and comparative transcriptomic identification of iridophore contribution to white barring in clownfish |
8 |
| Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities |
7 |
| In vivo multiphoton microscopy of melasma |
7 |
| Unexpected impact of esterification on the antioxidant activity and (photo) stability of a eumelanin from 6-dihydroxyindole-2-carboxylic acid |
7 |
| Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy |
7 |
| Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi |
7 |
| A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh/AXL(low) melanoma |
7 |
| Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development |
7 |
| BRN a POUerful driver of melanoma phenotype switching and metastasis |
7 |
| Subcellular localization and stability of MITF are modulated by the bHLH-Zip domain |
7 |
| Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma |
6 |
| In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization |
6 |
| Toll-like receptors 2 and 3 enhance melanogenesis and melanosome transport in human melanocytes |
6 |
| Regulation of melanocyte stem cell behavior by the niche microenvironment |
6 |
| Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology |
6 |
| MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma |
6 |
| CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study |
6 |
| BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy |
6 |
| The next-generation BET inhibitor, PLX5 delays melanoma growth in a CD8-mediated manner |
6 |
| Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion |
6 |
| Acid hydrolysis reveals a low but constant level of pheomelanin in human black to brown hair |
5 |
| Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in &ITBRAF&IT |
5 |
| Instability of BLOC-2 and BLOC-3 in Chinese patients with Hermansky-Pudlak syndrome |
5 |
| T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1 |
5 |
| Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma |
5 |
| Melanin quantification by in vitro and in vivo analysis of near-infrared fluorescence |
5 |
| Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts |
5 |
| Characterization of melanosomes and melanin in Japanese patients with Hermansky-Pudlak syndrome types and 9 |
5 |
| Role of melanoma inhibitory activity in melanocyte senescence |
5 |
| MITF controls the TCA cycle to modulate the melanoma hypoxia response |
5 |
| Analysis of the putative tumor suppressor gene cdkn2ab in pigment cells and melanoma of Xiphophorus and medaka |
4 |
| The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth |
4 |
| The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation |
4 |
